School of Public Health, University of Puerto Rico, San Juan, PR, USA.
Center for Research on Global Health, Graduate School of Public Health, University of Puerto Rico, Medical Sciences Campus, PO Box 365067, San Juan, PR, 00936-5067, USA.
J Urban Health. 2010 Mar;87(2):278-291. doi: 10.1007/s11524-009-9417-9.
HCV infection continues to spread at an alarming rate among IDU populations. The available evidence suggests that HCV is acquired relatively quickly following onset of injection. However, there are few prospective studies of HCV acquisition, particularly among IDU populations in resource-poor settings. A sample of young male heroin injectors with recent onset of injection (<4 years) was recruited in Hanoi, Vietnam for a prospective assessment of the early course of injection (n = 179). Both behavioral and biological assessments (including detailed retrospective assessment of injection initiation) were conducted at baseline and repeated at 6-month intervals for a period of 16 months. Variables associated with HCV infection (p value < 0.05) in bivariate analyses were considered for inclusion in logistic regression models to identify risk factors independently associated with HCV infection. HCV incidence was calculated by using the incidence density approach and was expressed in terms of person-years of observation. The baseline of prevalence of HCV was 46%. HCV significantly increased in relation to time since first injection, from 30% in subjects with </=10 months of injection risk to 70% in subjects with >/=30 months injection risk (p value = 0.0005). In multivariate logistic regression analysis, increasing age, incarceration in a drug detention facility (OR = 2.54; 95%CI 1.05, 6.15), and time since first injection remained significantly associated with HCV infection. Use of injection as primary mode of administration (OR = 2.56; 95%CI 0.98, 6.69) achieved marginal significance. After 16 months of follow-up, the incidence rate of HCV was 23.35 per 100 person-years and the mean time between first injection and first positive HCV test was 1.2 years. HCV is acquired much more rapidly among new injector populations than previously recognized, demonstrating the need for early behavioral intervention among new heroin-user populations. Particularly critical are interventions that target new heroin user populations, including interventions that improve understanding of viral transmission dynamics, that promote alternative strategies for drug sharing, and that delay initiation of injection.
HCV 感染继续在 IDU 人群中以惊人的速度传播。现有证据表明,HCV 在开始注射后相对较快地获得。然而,很少有 HCV 获得的前瞻性研究,特别是在资源匮乏环境中的 IDU 人群中。在越南河内,对近期开始注射(<4 年)的年轻男性海洛因注射者进行了一项前瞻性评估,以评估注射的早期过程(n=179)。在基线和 16 个月的 6 个月间隔期内,进行了行为和生物学评估(包括对注射开始的详细回顾性评估)。在单变量分析中,与 HCV 感染相关的变量(p 值<0.05)被认为包括在逻辑回归模型中,以确定与 HCV 感染独立相关的危险因素。使用发病率密度法计算 HCV 发病率,并以观察人年数表示。HCV 的基线流行率为 46%。HCV 与首次注射后的时间呈显著相关,从注射风险< = 10 个月的受试者的 30%增加到注射风险> = 30 个月的受试者的 70%(p 值=0.0005)。在多变量逻辑回归分析中,年龄增长、被监禁在戒毒所(OR=2.54;95%CI 1.05,6.15)和首次注射后的时间仍然与 HCV 感染显著相关。首次注射作为主要给药方式(OR=2.56;95%CI 0.98,6.69)达到边缘显著。随访 16 个月后,HCV 的发病率为 23.35/100 人年,首次注射到首次 HCV 检测阳性的平均时间为 1.2 年。新注射人群中 HCV 的获得速度比以前认识到的要快得多,这表明需要在新的海洛因使用者人群中进行早期行为干预。特别关键的是针对新的海洛因使用者人群的干预措施,包括提高对病毒传播动力学的理解、促进替代药物共享策略以及延迟注射开始的干预措施。